N. Neemann

Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor Specimens

M. Tiemann, Roman K. Thomas, C. Gloeckner, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

P53 disruptive mutation is a negative predictive factor in EGFR M+ NSCLC treated with TKI.

M. Tiemann, C. Hallas, F. Griesinger, 2015 .